Wegovy

Wire

Novo Nordisk slashes US cash prices for Wegovy and Ozempic
ByNNR November 17, 2025November 17, 2025

COPENHAGEN – Danish drugmaker Novo Nordisk said on Monday it has cut U.S. consumer prices for its weight-loss drug Wegovy and diabetes treatment Ozempic, expanding efforts by the company and the Trump administration to improve access to the blockbuster medicines….

Read More Novo Nordisk slashes US cash prices for Wegovy and Ozempic
Wire

Novo Nordisk to buy Akero for up to $5.2 billion
ByNNR October 9, 2025October 9, 2025

COPENHAGEN: Danish drugmaker Novo Nordisk will acquire U.S.-based Akero Therapeutics (AKRO.O) for up to $5.2 billion, gaining a promising liver disease treatment in the first major deal by its new chief executive to bolster its pipeline. The acquisition of Akero and…

Read More Novo Nordisk to buy Akero for up to $5.2 billion